Icares Medicus Inc - Asset Resilience Ratio
Icares Medicus Inc (6612) has an Asset Resilience Ratio of 10.98% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Icares Medicus Inc's Asset Resilience Ratio has changed over time. Check 6612 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Icares Medicus Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 6612 company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$349.30 Million | 10.98% |
| Total Liquid Assets | NT$349.30 Million | 10.98% |
Asset Resilience Insights
- Moderate Liquidity: Icares Medicus Inc has 10.98% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Icares Medicus Inc Industry Peers by Asset Resilience Ratio
Compare Icares Medicus Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Autek China Inc
SHE:300595 |
Medical Instruments & Supplies | 21.20% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.46% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
Annual Asset Resilience Ratio for Icares Medicus Inc (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Icares Medicus Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 10.98% | NT$349.30 Million ≈ $11.00 Million |
NT$3.18 Billion ≈ $100.19 Million |
+0.67pp |
| 2024-12-31 | 10.32% | NT$310.36 Million ≈ $9.78 Million |
NT$3.01 Billion ≈ $94.77 Million |
-20.45pp |
| 2023-12-31 | 30.76% | NT$587.17 Million ≈ $18.50 Million |
NT$1.91 Billion ≈ $60.13 Million |
+17.13pp |
| 2022-12-31 | 13.64% | NT$142.29 Million ≈ $4.48 Million |
NT$1.04 Billion ≈ $32.87 Million |
+11.84pp |
| 2021-12-31 | 1.80% | NT$17.38 Million ≈ $547.44K |
NT$965.87 Million ≈ $30.43 Million |
-- |
About Icares Medicus Inc
ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, United Kingdom, Japan, Spain, China, Germany, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataract… Read more